Insulin glargine and lixisenatide and Trastuzumab Intravenous
Determining the interaction of Insulin glargine and lixisenatide and Trastuzumab Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin glargine / lixisenatide
Brand name: Soliqua 100/33
Synonyms: Insulin Glargine and Lixisenatide
Generic Name: trastuzumab
Brand name: Herceptin, Kanjinti, Ogivri
Synonyms: Trastuzumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin glargine and lixisenatide-Trastuzumab-anns
- Insulin glargine and lixisenatide-Trastuzumab-dkst
- Insulin glargine and lixisenatide-Trastuzumab-dkst Intravenous
- Insulin glargine and lixisenatide-Trasylol
- Insulin glargine and lixisenatide-Travasol
- Insulin glargine and lixisenatide-Travatan
- Trastuzumab Intravenous-Insulin glargine and lixisenatide Subcutaneous
- Trastuzumab Intravenous-Insulin glargine, recombinant Subcutaneous
- Trastuzumab Intravenous-Insulin glulisine
- Trastuzumab Intravenous-Insulin Glulisine (Cartridges and Pens)
- Trastuzumab Intravenous-Insulin Glulisine (Vials)
- Trastuzumab Intravenous-Insulin glulisine Subcutaneous